Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
S. Jordan, D. Tyan, D. Stablein, M. McIntosh +12 more

